Discover open access scientific publications

Search, annotate, share and cite publications

Publications by Susan M. Chang

Radiation Therapy for Glioblastoma: American Society of Clinical Oncology Clinical Practice Guideline Endorsement of the American Society for Radiation Oncology Guideline

Journal of Clinical Oncology

English

7-Tesla Susceptibility-Weighted Imaging to Assess the Effects of Radiotherapy on Normal-Appearing Brain in Patients With Glioma

International Journal of Radiation Oncology Biology Physics

English

Incorporation of Biomarker Assessment in Novel Clinical Trial Designs: Personalizing Brain Tumor Treatments

Current Oncology Reports

Oncology

2010

English

Comparison of ADC Metrics and Their Association With Outcome for Patients With Newly Diagnosed Glioblastoma Being Treated With Radiation Therapy, Temozolomide, Erlotinib and Bevacizumab

Journal of Neuro-Oncology

English

Serial Analysis of 3D H-1 MRSI for Patients With Newly Diagnosed GBM Treated With Combination Therapy That Includes Bevacizumab

Journal of Neuro-Oncology

English

The Development of Reduced Diffusion Following Bevacizumab Therapy Identifies Regions of Recurrent Disease in Patients With High-Grade Glioma

English

End Point Assessment in Gliomas: Novel Treatments Limit Usefulness of Classical Macdonald's Criteria

Journal of Clinical Oncology

English

Perioperative Complications and Neurological Outcomes of First and Second Craniotomies Among Patients Enrolled in the Glioma Outcome Project

Journal of Neurosurgery

Surgery

Neurology

2003

English

Apparent Diffusion Coefficient and Fractional Anisotropy of Newly Diagnosed Grade II Gliomas

English

Phase II Trials of Erlotinib or Gefitinib in Patients With Recurrent Meningioma

Journal of Neuro-Oncology

English

Amanote Research

Discover open access scientific publications

Search, annotate, share and cite publications

Publications by Susan M. Chang

Radiation Therapy for Glioblastoma: American Society of Clinical Oncology Clinical Practice Guideline Endorsement of the American Society for Radiation Oncology Guideline

7-Tesla Susceptibility-Weighted Imaging to Assess the Effects of Radiotherapy on Normal-Appearing Brain in Patients With Glioma

Incorporation of Biomarker Assessment in Novel Clinical Trial Designs: Personalizing Brain Tumor Treatments

Comparison of ADC Metrics and Their Association With Outcome for Patients With Newly Diagnosed Glioblastoma Being Treated With Radiation Therapy, Temozolomide, Erlotinib and Bevacizumab

Serial Analysis of 3D H-1 MRSI for Patients With Newly Diagnosed GBM Treated With Combination Therapy That Includes Bevacizumab

The Development of Reduced Diffusion Following Bevacizumab Therapy Identifies Regions of Recurrent Disease in Patients With High-Grade Glioma

End Point Assessment in Gliomas: Novel Treatments Limit Usefulness of Classical Macdonald's Criteria

Perioperative Complications and Neurological Outcomes of First and Second Craniotomies Among Patients Enrolled in the Glioma Outcome Project

Apparent Diffusion Coefficient and Fractional Anisotropy of Newly Diagnosed Grade II Gliomas

Phase II Trials of Erlotinib or Gefitinib in Patients With Recurrent Meningioma